Navigation Links
Defective cell 'battery' plays central role in neurodegenerative disease
Date:1/17/2012

A devastating neurodegenerative disease that first appears in toddlers just as they are beginning to walk has been traced to defects in mitochondria, the 'batteries' or energy-producing power plants of cells. This finding by a team of researchers, led by investigators from the Montreal Neurological Institute and Hospital The Neuro- at McGill University, was published in this week's issue of the Proceedings of the National Academy of Sciences of the USA (PNAS). The research, which was highlighted as "Novel & Newsworthy" by the American Society for Cell Biology (ASCB), significantly increases understanding of the disease and reveals an important common link with other neurodegenerative diseases, providing renewed hope and potential new therapeutic strategies for those affected around the world.

The disorder, Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS), primarily affects the cerebellum, a centre for movement coordination in the brain. ARSACS was first identified in the late 1970s in a large group of patients from the Charlevoix and Saguenay regions of Quebec. The incidence of ARSACS in this 'founder' population is 1 in 1,500-2,000 births, with a high carrier rate of 1 in 23. ARSACS strikes at an early age. Symptoms, which worsen over time, include poor motor coordination, spastic stiffness, muscle wasting, uncoordinated eye movements and slurred speech. Most patients with the disease are wheelchair-bound by their early 40s and have a reduced life expectancy. ARSACS is not unique to French-Canada as scientists have now found over 100 separate mutations in people worldwide including Japan, Turkey and across Western Europe.

"This finding is the first important advancement in the 10 years since the identification of the mutated gene because it gives an indication of the underlying cellular mechanism of the disease," says Dr. Bernard Brais, neurologist at The Neuro, "and is a vital first step towards developing therapeutic strategies for ARSACS." In 2000, scientists identified the gene associated with the disease, called SACS, which produces a massive 4,579 amino acid protein called sacsin, but until now the role or the function of the sacsin protein has been unknown. The multi-institutional collaborative research led by Dr. Brais and Dr. Peter McPherson at The Neuro as well as Dr. Paul Chapple at Queen Mary, University of London indicates that that the sacsin protein has a mitochondrial function, and that mutations causing ARSACS are linked to a dysfunction of mitochondria in neurons.

"By studying neurons in culture as well as in knockout mice (which do not produce sacsin), the team found that loss of the sacsin protein results in abnormally shaped and poorly functioning mitochondria," says Dr. Peter McPherson, researcher at The Neuro. This disruption led to defective changes in the neurons and eventual death of the neurons. In the knockout mice, these disruptions led to neuron death specifically in the cerebellum, suggesting that this is the basis for the neurodegenerative impairments suffered by ARSACS patients.

"Mitochondrial dysfunction has also been identified in major neurodegenerative diseases such as Parkinson, Alzheimer, and Huntington diseases," says Dr. McPherson. "This common link means that research being done on a large-scale on these other diseases may prove critically informative to rarer neurological diseases such as ARSACS, and the inverse may be true, our findings may be fundamental to the study and treatment of other neurodegenerative diseases."


'/>"/>
Contact: Anita Kar
anita.kar@mcgill.ca
514-398-3376
McGill University
Source:Eurekalert

Related biology news :

1. Sight fails when defective eye cells cripple renewal
2. Defective cell surface glue is key to tumor invasion
3. Defective protein is a double hit for ataxia
4. Research project yields better understanding of the defective protein that causes cystic fibrosis
5. DigitalPersona Goes Mobile with New U.are.U 5100 Fingerprint Sensors for Battery-Powered Mobile ID Devices
6. Battery research: Bionics reduces filling time
7. Lithium-sulfur battery research receives $5 million from DOE
8. Livermore researchers develop battery-less chemical detector
9. BASF and Karlsruhe Institute of Technology develop tomorrows battery materials
10. WSU researchers use super-high pressures to create super battery
11. Synthetic cells shed biological insights while delivering battery power
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access System ... over the next decade to reach approximately $1,580 million by 2025. ... forecasts for all the given segments on global as well as ...
(Date:3/22/2017)... March 21, 2017   Neurotechnology , a ... technologies, today announced the release of the ... provides improved facial recognition using up to 10 ... single computer. The new version uses deep neural-network-based ... and it utilizes a Graphing Processing Unit (GPU) ...
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela Merkel ... came to the DERMALOG stand together with the Japanese Prime Minster Shinzo ... At the largest German biometrics company the two government leaders could see ... as well as DERMALOG´s multi-biometrics system.   Continue ... ...
Breaking Biology News(10 mins):
(Date:7/26/2017)... 2017 /PRNewswire/ - Caprion Biosciences Inc., a world leading specialty CRO ... proteins predictive of early stage (latent) Mycobacterium tuberculosis (Mtb) infection ... monitoring (MRM-MS) platform. ... Caprion Biosciences Inc. (CNW Group/Caprion Biosciences) ... The new data, recently published ...
(Date:7/26/2017)... ... 2017 , ... Proscia Inc. , a software solutions provider for digital ... 2017 MedCity CONVERGE. His talk, “The Davids vs. the Cancer Goliath,” will discuss how ... (AI, VR, Big Data) sectors are taking aim at cancer diagnosis and research. Proscia ...
(Date:7/26/2017)... ... July 25, 2017 , ... ... garner a better understanding of the considerations needed for designing ideal guide RNAs ... use of CRISPR-Cas9 to create targeted double-strand breaks in genomic DNA has greatly ...
(Date:7/26/2017)... ... 26, 2017 , ... Spectral imaging is a non-destructive technique ... This unique capability combines high resolution imaging with spectral analysis. The system ... for chemical analysis, quality control, and decision-making. , Snapshot spectral imaging is key ...
Breaking Biology Technology: